Hypothalamic dysfunction in obesity: from mice to men
Licio A. Velloso
Department of Internal Medicine
and Laboratory of Cell Signaling
University of Campinas, Brazil
January 27th 2015
Licio A. Velloso is a Professor of Medicine at the Department of Internal Medicine, University of Campinas, Brazil. He is the Head of the Laboratory of Cell Signaling. Dr. Velloso obtained a MD from the University of Campinas Medical School in 1986. The PhD was obtained from the University of Uppsala in Sweden in 1993. He was a Post- Doctoral fellow at the Mario Saad Lab, University of Campinas, 1994 and a Post- Doctoral fellow at the Ron Kahn Lab, Joslin Diabetes Center, Harvard, 1995. Dr. Velloso research is focused on the molecular and cellular mechanisms involved in the hypothalamic dysfunction in obesity and associated conditions. He published more than 200 papers, which have been cited more than 6000 times. Dr. Velloso H index is 42.
Neuro-skeletal network and bone repair
Meriem Lamghari
New Therapies Group
Institute for Molecular and Cell Biology (IBMC)
Institute of Biomedical Engineering (INEB)
University of Porto
December, 12th 2014
SIRTUINS, NAD, AND HEALTH
Leonard Guarente
Novartis Professor of Biology and
Director of the Glenn Labs for the Science of Aging
MIT
June, 30th 2014
Leonard P. Guarente is an American biologist best known for his research on life span extension. Based on the discovery that SIR2 is a key regulator of longevity in both yeast and worms, he is interested in determining whether this highly-conserved gene also governs longevity in other organisms, including mammals. Leonard P. Guarente is the Novartis Professor of Biology and Director of the Glenn Labs for the Science of Aging at MIT and an affiliate of the Koch Institute for Integrative Cancer Research. LG consults for GSK, Chronos, Inside Tracker, and Elysiumhealth.
Licio A. Velloso
Department of Internal Medicine
and Laboratory of Cell Signaling
University of Campinas, Brazil
January 27th 2015
Licio A. Velloso is a Professor of Medicine at the Department of Internal Medicine, University of Campinas, Brazil. He is the Head of the Laboratory of Cell Signaling. Dr. Velloso obtained a MD from the University of Campinas Medical School in 1986. The PhD was obtained from the University of Uppsala in Sweden in 1993. He was a Post- Doctoral fellow at the Mario Saad Lab, University of Campinas, 1994 and a Post- Doctoral fellow at the Ron Kahn Lab, Joslin Diabetes Center, Harvard, 1995. Dr. Velloso research is focused on the molecular and cellular mechanisms involved in the hypothalamic dysfunction in obesity and associated conditions. He published more than 200 papers, which have been cited more than 6000 times. Dr. Velloso H index is 42.
Neuro-skeletal network and bone repair
Meriem Lamghari
New Therapies Group
Institute for Molecular and Cell Biology (IBMC)
Institute of Biomedical Engineering (INEB)
University of Porto
December, 12th 2014
SIRTUINS, NAD, AND HEALTH
Leonard Guarente
Novartis Professor of Biology and
Director of the Glenn Labs for the Science of Aging
MIT
June, 30th 2014
Leonard P. Guarente is an American biologist best known for his research on life span extension. Based on the discovery that SIR2 is a key regulator of longevity in both yeast and worms, he is interested in determining whether this highly-conserved gene also governs longevity in other organisms, including mammals. Leonard P. Guarente is the Novartis Professor of Biology and Director of the Glenn Labs for the Science of Aging at MIT and an affiliate of the Koch Institute for Integrative Cancer Research. LG consults for GSK, Chronos, Inside Tracker, and Elysiumhealth.
Integrative genomics of ageing: New approaches for an “old” problem
João Pedro Magalhães
Integrative Genomics of Ageing Group
University of Liverpool
United Kingdom
April, 24th 2014
João Pedro de Magalhães graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and then obtained his PhD in 2004 from the University of Namur in Belgium, where he worked in the Ageing and Stress Group lead by Olivier Toussaint. Following a postdoc with genomics pioneer George Church at Harvard Medical School in Boston, USA, in 2008 João Pedro de Magalhães joined the University of Liverpool to develop his own group on genomic approaches to ageing. Now a senior lecturer, João Pedro de Magalhães leads the Integrative Genomics of Ageing Group (http://www.liv.ac.uk/~aging/) which focuses on understanding the genetic, cellular, and molecular mechanisms of ageing. The group’s research integrates different strategies but its focal point is developing and applying experimental and computacional methods that help bridge the gap between genotype and phenotype, a major challenge of the post-genome era, and help decipher the human genome and how it regulates complex processes like ageing.
João Pedro Magalhães
Integrative Genomics of Ageing Group
University of Liverpool
United Kingdom
April, 24th 2014
João Pedro de Magalhães graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and then obtained his PhD in 2004 from the University of Namur in Belgium, where he worked in the Ageing and Stress Group lead by Olivier Toussaint. Following a postdoc with genomics pioneer George Church at Harvard Medical School in Boston, USA, in 2008 João Pedro de Magalhães joined the University of Liverpool to develop his own group on genomic approaches to ageing. Now a senior lecturer, João Pedro de Magalhães leads the Integrative Genomics of Ageing Group (http://www.liv.ac.uk/~aging/) which focuses on understanding the genetic, cellular, and molecular mechanisms of ageing. The group’s research integrates different strategies but its focal point is developing and applying experimental and computacional methods that help bridge the gap between genotype and phenotype, a major challenge of the post-genome era, and help decipher the human genome and how it regulates complex processes like ageing.
